Global Infectious Disease Diagnostics Market Report 2023: Sector is Expected to Reach $49 Billion by 2030 at a CAGR of 6.5% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product, By Test, By Technology, By Disease, By End-user – Industry Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

The global infectious disease diagnostics market size was valued at USD 27850.14 million in 2021 and is poised to grow from USD 29632.56 million in 2022 to USD 49041.76 million by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

Companies Mentioned

• Abbott Laboratories (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• BioMerieux SA (France)
• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Quidel Corporation(US)
• Hologic, Inc. (US)
• Siemens Healthineers AG (Germany)
• Becton, Dickinson, and Company (US)
• PerkinElmer Inc. (US)
• QIAGEN (Netherlands)
• Grifols S.A. (Spain)
• DiaSorin S.p.A (Italy)
• Bio-Rad Laboratories, Inc. (US)
• Sysmex Corporation (Japan)
• Ortho Clinical Diagnostics (US)
• Luminex Corporation (US)
• Meridian Bioscience (US)
• Danaher Corporation (US)
• Mesa Biotech (US)

Infectious disease diagnostics refer to the process of identifying the presence of infectious agents such as bacteria, viruses, fungi, and parasites in human or animal samples. The infectious disease diagnostics market is driven by the increasing prevalence of infectious diseases, the need for rapid and accurate diagnostic tests, and the growing demand for point-of-care testing.

The Global Infectious Disease Diagnostics Market is segmented based on Product, Test, Technology, Disease, End-User, and Region. Based on Product market is segmented into Reagents, Kits, Consumables, Instruments, and Software & Services. Based on Test Type it is categorized into Laboratory and POC. Based on Technology the Infectious Disease Diagnostics Market is segmented into Immunodiagnostics, Microbiology, PCR, NGS, and INAAT.

By Disease the market is categorized into COVID-19, Hepatitis, HAI, HIV, Influenza, CT/NG, HPV, TB, and Other Infectious Diseases. By End User, the Infectious Disease Diagnostics Market studied is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users. Based on the Region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The infectious disease diagnostics market is expected to grow significantly due to various drivers, such as the increasing prevalence of infectious diseases. As infectious diseases continue to spread, the demand for diagnostic tests is expected to increase, as timely diagnosis is critical for effective treatment and disease management.

The need for rapid and accurate diagnostic tests is another driver of the market, as healthcare providers require accurate and reliable diagnostic results to make informed treatment decisions. The growing demand for point-of-care testing is also driving the market, as point-of-care tests enable rapid diagnosis and treatment initiation, particularly in resource-limited settings.

Restraint

The high cost of diagnostic tests is a major restraint for the growth of the infectious disease diagnostics market. The complexity of diagnostic tests and the need for advanced technologies and equipment make them expensive, which has limited their adoption in some segments of the healthcare industry.

Market Trends

Molecular diagnostics is an emerging trend in the infectious disease diagnostics market, as it enables the rapid and accurate detection of infectious agents using nucleic acid amplification techniques.

Molecular diagnostics are becoming increasingly popular due to their high sensitivity and specificity, which allows for accurate and timely diagnosis.

Point-of-care testing is another trend in the infectious disease diagnostics market, as it enables rapid diagnosis and treatment initiation at the point of care. Point-of-care tests are becoming increasingly popular due to their ease of use and portability, which allows for testing in resource-limited settings.

For more information about this report visit https://www.researchandmarkets.com/r/82mb8b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900